{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:47:15Z","timestamp":1747205235751,"version":"3.40.5"},"posted":{"date-parts":[[2024,7,2]]},"group-title":"In Review","reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,7]]},"abstract":"<title>Abstract<\/title>\n        <p>Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling side effect of cancer chemotherapy that can often limit treatment options for cancer patients or have life-long neurodegenerative consequences that reduce the patient\u2019s quality of life. CIPN is caused by the detrimental actions of various chemotherapeutic agents on peripheral axons. Currently, there are no approved preventative measures or treatment options for CIPN, highlighting the need for the discovery of novel therapeutics and improving our understanding of disease mechanisms. In this study, we utilized human-induced pluripotent stem cell (hiPSC)-derived motor neurons as a platform to mimic axonal damage after treatment with vincristine, a chemotherapeutic used for the treatment of breast cancers, osteosarcomas, and leukemia. We screened a total of 1902 small molecules for neuroprotective properties in rescuing vincristine-induced axon growth deficits. From our primary screen, we identified 38 hit compounds that were subjected to secondary dose response screens. Six compounds showed favorable pharmacological profiles \u2013 AZD7762, A-674563, Blebbistatin, Glesatinib, KW-2449, and Pelitinib, all novel neuroprotectants against vincristine toxicity to neurons. In addition, four of these six compounds also showed efficacy against vincristine-induced growth arrest in human iPSC-derived sensory neurons. In this study, we utilized high-throughput screening of a large library of compounds in a therapeutically relevant assay. We identified several novel compounds that are efficacious in protecting different neuronal subtypes from the toxicity induced by a common chemotherapeutic agent, vincristine which could have therapeutic potential in the clinic.<\/p>","DOI":"10.21203\/rs.3.rs-4545853\/v1","type":"posted-content","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:59:00Z","timestamp":1719953940000},"source":"Crossref","is-referenced-by-count":0,"title":["Identification of novel neuroprotectants against vincristine-induced neurotoxicity in iPSC-derived neurons"],"prefix":"10.21203","author":[{"given":"Veselina","family":"Petrova","sequence":"first","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R","family":"Snavely","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Splaine","sequence":"additional","affiliation":[{"name":"Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Zhen","sequence":"additional","affiliation":[{"name":"Boston Childrens Hospital: Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagat","family":"Singh","sequence":"additional","affiliation":[{"name":"Boston Childrens Hospital: Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"Pandey","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuchuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anya","family":"Cheng","sequence":"additional","affiliation":[{"name":"Boston Childrens Hospital: Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Hermawan","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee B","family":"Barrett","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Harvard Medical School Center for Blood Research: Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-3897","authenticated-orcid":false,"given":"Clifford","family":"Woolf","sequence":"additional","affiliation":[{"name":"Boston Childrens Hospital: Boston Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623319861937","author":"Eldridge S","year":"2020","unstructured":"Eldridge S, Guo L, Hamre J (2020) A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models, Toxicologic Pathology, vol. 48, no. 1. SAGE Publications Inc., pp. 190\u2013201, Jan. 01, 10.1177\/0192623319861937"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS20061451","author":"Zajaczkowsk\u0105 R","year":"2019","unstructured":"Zajaczkowsk\u0105 R, Kocot-K\u0119pska M, Leppert W, Wrzosek A, Mika J, Wordliczek J (2019) Mechanisms of Chemotherapy-Induced Peripheral Neuropathy, Int J Mol Sci, vol. 20, no. 6, Mar. 10.3390\/IJMS20061451"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fnins.2017.00481","article-title":"A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fukuda Y","year":"2017","unstructured":"Fukuda Y, Li Y, Segal RA (2017) A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy. Front NeuroSci 11:481. Frontiers Media S.A.10.3389\/fnins.2017.00481","journal-title":"Front NeuroSci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.06.044","article-title":"Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead","author":"Martino E","year":"2018","unstructured":"Martino E et al (2018) Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. 10.1016\/j.bmcl.2018.06.044"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.14740\/jocmr.v6i4.1856","article-title":"Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy","volume":"6","author":"Okada N","unstructured":"Okada N et al (May 2014) Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy. J Clin Med Res 6(4):252\u2013260. 10.14740\/jocmr.v6i4.1856","journal-title":"J Clin Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.88","author":"Argyriou AA","year":"2017","unstructured":"Argyriou AA, Bruna J, Genazzani AA, Cavaletti G (2017) Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics, Nature Reviews Neurology 2017 13:8, vol. 13, no. 8, pp. 492\u2013504, Jun. 10.1038\/nrneurol.2017.88"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154642.45474.28","author":"Verstappen CCP","year":"2005","unstructured":"Verstappen CCP et al (2005) Mar., Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening, Neurology, vol. 64, no. 6, pp. 1076\u20131077, 10.1212\/01.WNL.0000154642.45474.28"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"271682","DOI":"10.3389\/FNMOL.2017.00174\/BIBTEX","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova H","unstructured":"Starobova H, Vetter I (May 2017) Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci 10:271682. 10.3389\/FNMOL.2017.00174\/BIBTEX","journal-title":"Front Mol Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/S12984-021-00818-2","author":"Wang AB","year":"2021","unstructured":"Wang AB, Housley SN, Flores AM, Kircher SM, Perreault EJ, Cope TC (2021) A review of movement disorders in chemotherapy-induced neurotoxicity, J Neuroeng Rehabil, vol. 18, no. 1, p. 16, Dec. 10.1186\/S12984-021-00818-2"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/CTS.12912","author":"Xiong C","year":"2021","unstructured":"Xiong C et al (2021) Mar., Human Induced Pluripotent Stem Cell Derived Sensory Neurons are Sensitive to the Neurotoxic Effects of Paclitaxel, Clin Transl Sci, vol. 14, no. 2, pp. 568\u2013581, 10.1111\/CTS.12912"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105391","article-title":"Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons","author":"Schinke C","year":"2021","unstructured":"Schinke C et al (2021) Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons. 10.1016\/j.nbd.2021.105391"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81335-z","article-title":"A directional 3D neurite outgrowth model for studying motor axon biology and disease","volume":"11","author":"Spijkers XM","year":"2080","unstructured":"Spijkers XM, Pasteuning-Vuhman S, Dorleijn JC, Vulto P, Wevers NR, and, Jeroen R, Pasterkamp (2080) A directional 3D neurite outgrowth model for studying motor axon biology and disease. Sci Rep | 11. 10.1038\/s41598-021-81335-z","journal-title":"Sci Rep |"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIV.2017.08.014","author":"Rana P","year":"2017","unstructured":"Rana P, Luerman G, Hess D, Rubitski E, Adkins K, Somps C (2017) Utilization of iPSC-derived human neurons for high-throughput drug-induced peripheral neuropathy screening, Toxicology in Vitro, vol. 45, pp. 111\u2013118, Dec. 10.1016\/J.TIV.2017.08.014"},{"issue":"12","key":"ref14","doi-asserted-by":"publisher","DOI":"10.1242\/DMM.049471","article-title":"An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity","volume":"15","author":"Tsai NW","unstructured":"Tsai NW et al (Dec. 2022) An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity. Dis Model Mech 15(12). 10.1242\/DMM.049471","journal-title":"Dis Model Mech"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/MUS.24647","author":"Courtemanche H","year":"2015","unstructured":"Courtemanche H et al (2015) Dec., Vincristine-induced neuropathy: Atypical electrophysiological patterns in children, Muscle Nerve, vol. 52, no. 6, pp. 981\u2013985, 10.1002\/MUS.24647"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2014.03.019","article-title":"Intrinsic Membrane Hyperexcitability of ALS Patient-Derived Motor Neurons","volume":"7","author":"Wainger BJ","year":"2014","unstructured":"Wainger BJ et al (2014) Intrinsic Membrane Hyperexcitability of ALS Patient-Derived Motor Neurons. Cell Rep 7(1):1\u201311. 10.1016\/j.celrep.2014.03.019","journal-title":"Cell Rep"},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/J.STEMCR.2023.03.006","article-title":"Scalable generation of sensory neurons from human pluripotent stem cells","volume":"18","author":"Deng T","unstructured":"Deng T et al (Apr. 2023) Scalable generation of sensory neurons from human pluripotent stem cells. Stem Cell Rep 18(4):1030. 10.1016\/J.STEMCR.2023.03.006","journal-title":"Stem Cell Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01126-2","author":"Chen Y","year":"2021","unstructured":"Chen Y et al (2021) May., A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells, Nature Methods 2021 18:5, vol. 18, no. 5, pp. 528\u2013541, 10.1038\/s41592-021-01126-2"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.10.109","article-title":"iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid b Combination for Alzheimer\u2019s Disease","author":"Kondo T","unstructured":"Kondo T, Imamura K, Funayama M, Kaji R iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid b Combination for Alzheimer\u2019s Disease, 10.1016\/j.celrep.2017.10.109"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118020","article-title":"Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells","author":"Wheeler HE","year":"2015","unstructured":"Wheeler HE, Wing C, Delaney SM, Komatsu M, Dolan ME (2015) Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells. 10.1371\/journal.pone.0118020"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.scr.2017.06.006","article-title":"Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy HHS Public Access Graphical abstract","volume":"22","author":"Wing C","year":"2017","unstructured":"Wing C, Komatsu M, Delaney SM, Krause M, Wheeler HE, Dolan ME (2017) Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy HHS Public Access Graphical abstract. Stem Cell Res 22:79\u201388. 10.1016\/j.scr.2017.06.006","journal-title":"Stem Cell Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.V126.23.2491.2491","author":"Wang ES","year":"2015","unstructured":"Wang ES et al (2015) Dec., Plasma Vincristine Levels Are 100-Fold Higher with Marqibo\u00ae (Vincristine Sulfate LIPOSOME Injection) in Place of Standard Vincristine in Combination Chemotherapy of Patients\u2009\u2265\u200960 Years Old with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL), Blood, vol. 126, no. 23, pp. 2491\u20132491, 10.1182\/BLOOD.V126.23.2491.2491"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-9-23\/FIGURES\/7","article-title":"The secret life of kinases: Functions beyond catalysis","volume":"9","author":"Rauch J","unstructured":"Rauch J, Volinsky N, Romano D, Kolch W (Oct. 2011) The secret life of kinases: Functions beyond catalysis. Cell Communication Signal 9(1):1\u201328. 10.1186\/1478-811X-9-23\/FIGURES\/7","journal-title":"Cell Communication Signal"},{"issue":"12","key":"ref24","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/J.CHEMBIOL.2019.10.005","article-title":"Development of MAP4 kinase inhibitors as motor-neuron-protecting agents","volume":"26","author":"Bos PH","unstructured":"Bos PH et al (Dec. 2019) Development of MAP4 kinase inhibitors as motor-neuron-protecting agents. Cell Chem Biol 26(12):1703. 10.1016\/J.CHEMBIOL.2019.10.005","journal-title":"Cell Chem Biol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1021\/JM500065F\/SUPPL_FILE\/JM500065F_SI_002.PDF","author":"Salado IG","year":"2014","unstructured":"Salado IG et al (2014) Mar., Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis, J Med Chem, vol. 57, no. 6, pp. 2755\u20132772, 10.1021\/JM500065F\/SUPPL_FILE\/JM500065F_SI_002.PDF"},{"issue":"e5","key":"ref26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neuron.2020.03.005","article-title":"The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice","volume":"106","author":"Gerbino V","year":"2020","unstructured":"Gerbino V, Kaunga E, Ye J, Guarnieri P, Lutz CM, Maniatis Correspondence T (2020) The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice. Neuron 106(e5):789\u2013805. 10.1016\/j.neuron.2020.03.005","journal-title":"Neuron"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2647-1","author":"Chauhan M","year":"2020","unstructured":"Chauhan M, Modi PK, Sharma P (2020) Aberrant activation of neuronal cell cycle caused by dysregulation of ubiquitin ligase Itch results in neurodegeneration, Cell Death & Disease 2020 11:6, vol. 11, no. 6, pp. 1\u201313, Jun. 10.1038\/s41419-020-2647-1"},{"issue":"3","key":"ref28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1523\/jneurosci.18-03-00830.1998","article-title":"Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress","volume":"18","author":"Park DS","year":"1998","unstructured":"Park DS et al (1998) Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci 18(3):830\u2013840. 10.1523\/jneurosci.18-03-00830.1998","journal-title":"J Neurosci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/JNNP-2021-328323","author":"Park SB","year":"2023","unstructured":"Park SB, Cetinkaya-Fisgin A, Argyriou AA, H\u00f6ke A, Cavaletti G, Alberti P (2023) Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence, J Neurol Neurosurg Psychiatry, vol. 94, no. 11, pp. 962\u2013972, Nov. 10.1136\/JNNP-2021-328323"},{"issue":"5","key":"ref30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4161\/CBT.23761","article-title":"Chemotherapy induced DNA damage response: Convergence of drugs and pathways","volume":"14","author":"Woods D","unstructured":"Woods D, Turchi JJ (May 2013) Chemotherapy induced DNA damage response: Convergence of drugs and pathways. Cancer Biol Ther 14(5):379. 10.4161\/CBT.23761","journal-title":"Cancer Biol Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.03.004","article-title":"Cell Stem Cell Article Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1","author":"Kiskinis E","unstructured":"Kiskinis E et al Cell Stem Cell Article Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1, 10.1016\/j.stem.2014.03.004"},{"issue":"503","key":"ref32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1126\/SCITRANSLMED.AAU0164\/SUPPL_FILE\/AAU0164_TABLE_S4.XLSX","article-title":"Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice","volume":"11","author":"Tang X","unstructured":"Tang X et al (Jul. 2019) Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice. Sci Transl Med 11(503):31. 10.1126\/SCITRANSLMED.AAU0164\/SUPPL_FILE\/AAU0164_TABLE_S4.XLSX","journal-title":"Sci Transl Med"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/S13287-022-03216-0","article-title":"KW-2449 and VPA exert therapeutic effects on human neurons and cerebral organoids derived from MECP2-null hESCs","volume":"13","author":"Xu YJ","unstructured":"Xu YJ et al (Dec. 2022) KW-2449 and VPA exert therapeutic effects on human neurons and cerebral organoids derived from MECP2-null hESCs. Stem Cell Res Ther 13(1). 10.1186\/S13287-022-03216-0","journal-title":"Stem Cell Res Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1101\/2022.11.01.514550","author":"Nguyen LD","year":"2022","unstructured":"Nguyen LD et al (2022) Nov., Small Molecule Inducers of Neuroprotective miR-132 Identified by HTS-HTS in Human iPSC-derived Neurons, bioRxiv, p. 2022.11.01.514550, 10.1101\/2022.11.01.514550"},{"issue":"6","key":"ref35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/J.1471-4159.2011.07638.X","article-title":"Myosin II activity regulates neurite outgrowth and guidance in response to chondroitin sulfate proteoglycans","volume":"120","author":"Yu P","unstructured":"Yu P, Santiago LY, Katagiri Y, Geller HM (Mar. 2012) Myosin II activity regulates neurite outgrowth and guidance in response to chondroitin sulfate proteoglycans. J Neurochem 120(6):1117. 10.1111\/J.1471-4159.2011.07638.X","journal-title":"J Neurochem"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1011258108\/-\/DCSUPPLEMENTAL","author":"Hur EM","year":"2011","unstructured":"Hur EM et al (2011) Mar., Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules, Proc Natl Acad Sci U S A, vol. 108, no. 12, pp. 5057\u20135062, 10.1073\/PNAS.1011258108\/-\/DCSUPPLEMENTAL"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.02.466937","author":"Szu T","year":"2021","unstructured":"Szu T et al (2021) Nov., Screening for axon regeneration promoting compounds with human iPSC-derived motor neurons, bioRxiv, p. 2021.11.02.466937, 10.1101\/2021.11.02.466937"},{"issue":"3","key":"ref38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/S00280-014-2380-5","article-title":"Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors","volume":"73","author":"Sausville E","year":"2014","unstructured":"Sausville E et al (2014) Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors. Cancer Chemother Pharmacol 73(3):539. 10.1007\/S00280-014-2380-5","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"864910","DOI":"10.3389\/FPAIN.2022.864910","article-title":"Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions","volume":"3","author":"Rodwin RL","year":"2022","unstructured":"Rodwin RL, Siddiq NZ, Ehrlich BE, Lustberg MB (2022) Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. Front Pain Res 3:864910. 10.3389\/FPAIN.2022.864910","journal-title":"Front Pain Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18716-5","author":"Burgess BL","year":"2022","unstructured":"Burgess BL, Cho E, Honigberg L (2022) Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin, Scientific Reports 2022 12:1, vol. 12, no. 1, pp. 1\u20139, Sep. 10.1038\/s41598-022-18716-5"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4545853\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4545853\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T19:17:02Z","timestamp":1722539822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4545853\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":40,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4545853\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s00018-024-05340-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,7,2]]},"subtype":"preprint"}}